AiyerR, BarkinRL, BhatiaA: Treatment of neuropathic pain with venlafaxine: A systematic review. Pain Med, 18:1999–2012, 2017.
2.
AmrMA-M, AminTT, HablasHR: Psychiatric disorders in a sample of Saudi Arabian Adolescents with Sickle Cell Disease. Child Youth Care Forum, 39:151–166, 2010.
3.
BeckerM, AxelrodDJ, OyesanmiO, MarkovDD, KunkelEJ: Hematologic problems in psychosomatic medicine. Psychiatr Clin North Am, 30:739–759, 2007.
4.
BentonTD, IfeagwuJA, Smith-WhitleyK: Anxiety and depression in children and adolescents with sickle cell disease. Curr Psychiatry Rep, 9:114–121, 2007.
5.
BrandowAM, DeBaunMR: Key components of pain management for children and adults with sickle cell disease. Hematol Oncol Clin North Am, 32:535–550, 2018.
6.
BridgeJA, IyengarS, SalaryCB, BarbeRP, BirmaherB, PincusHA, RenL, BrentDA: Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA, 297:1683–1696, 2007.
7.
CobhamVE, HicklingA, KimballH, ThomasHJ, ScottJG, MiddeldorpCM: Systematic review: Anxiety in children and adolescents with chronic medical conditions. J Am Acad Child Adolesc Psychiatry, 59:595–618, 2020.
8.
ConnollySD, BernsteinGA: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry, 46:267–283, 2007.
9.
DwyerJB, BlochMH: Antidepressants for pediatric patients. Curr Psychiatr, 18:26f–42f, 2019.
10.
FoongAi-Leng, Kelly GrindrodA, TejalPatel, JamieKellar: Demystifying serotonin syndrome (or serotonin toxicity). Canad Fam Phys Med Fam Canad, 64:720–727, 2018.
11.
JannMW, SladeJH: Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy, 27:1571–1587, 2007.
12.
JerrellJM, TripathiA, McIntyreRS: Prevalence and treatment of depression in children and adolescents with sickle cell disease: A retrospective cohort study. Prim Care Companion CNS Disord, 13:e1–e7, 2011a.
13.
JerrellJM, TripathiA, StallworthJR: Pain management in children and adolescents with sickle cell disease. Am J Hematol, 86:82–84, 2011b.
14.
LevensonJL, McClishDK, DahmanBA, Bovbjerg VEA. C, iteroV. de, PenberthyLT, AisikuIP, RobertsJD, RoseffSD, SmithWR: Depression and anxiety in adults with sickle cell disease: The PiSCES project. Psychosom Med, 70:192–196, 2008.
15.
MahdiN, Al-OlaK, KhalekNA, AlmawiWY: Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis. J Pediatr Hematol Oncol, 32:345–349, 2010.
16.
MyrvikMP, BurksLM, HoffmanRG, DasguptaM, PanepintoJA: Mental health disorders influence admission rates for pain in children with sickle cell disease. Pediatr Blood Cancer, 60:1211–1214, 2013.
17.
MyrvikMP, CampbellAD, DavisMM, ButcherJL: Impact of psychiatric diagnoses on hospital length of stay in children with sickle cell anemia. Pediatr Blood Cancer, 58:239–243, 2012.
18.
PowellRE, LovettPB, Crawford AJ. McAna, AxelrodD, WardL, PulteD: A multidisciplinary approach to impact acute care utilization in sickle cell disease. Am J Med Qual, 33:127–131, 2018.
19.
ReaderSK, RockmanLM, OkonakKM, RuppeNM, KeelerCN, KazakAE: Systematic review: Pain and emotional functioning in pediatric sickle cell disease. J Clin Psychol Med Settings, 27:343–365, 2020.
20.
RynnMA, RiddleMA, YeungPP, KunzNR: Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: Two placebo-controlled trials. Am J Psychiatry, 164:290–300, 2007.
21.
RynnMA, SiquelandL, RickelsK: Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry, 158:2008–2014, 2001.
22.
SkopBP, BrownTM: Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics (Washington, D.C.), 37:12–16, 1996.
23.
StrawnJR, PrakashA, ZhangQ, PangalloBA, StroudCE, CaiN, FindlingRL: A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry, 54:283–293, 2015a.
24.
StrawnJR, WelgeJA, WehryAM, KeeshinB, RynnMA: Efficacy and tolerability of antidepressants in pediatric anxiety disorders: A systematic review and meta-analysis. Depress Anxiety, 32:149–157, 2015b.
